Indivior Pharmaceuticals, Inc. (INDV)
34.93
+0.10
(+0.29%)
USD |
NASDAQ |
Sep 04, 16:00
34.93
0.00 (0.00%)
After-Hours: 20:00
Indivior Pharmaceuticals Cash and Short Term Investments (Annual) : 195.00M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 195.00M |
| December 31, 2024 | 320.00M |
| December 31, 2023 | 410.00M |
| December 31, 2022 | 893.00M |
| December 31, 2021 | 1.102B |
| December 31, 2020 | 858.00M |
| December 31, 2019 | 1.060B |
| December 31, 2018 | 924.00M |
| Date | Value |
|---|---|
| December 31, 2017 | 863.00M |
| December 31, 2016 | 692.00M |
| December 31, 2015 | 467.00M |
| December 31, 2014 | 331.00M |
| December 31, 2013 | 7.00M |
| December 31, 2012 | 25.00M |
| December 31, 2011 | 7.00M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Supernus Pharmaceuticals, Inc. | 308.67M |
| Liquidia Corp. | 190.68M |
| Corcept Therapeutics, Inc. | 372.15M |
| Harrow, Inc. | 72.93M |
| Collegium Pharmaceutical, Inc. | 406.53M |